For instance, the prognostic implications of an IDHmut glioma with both 1p/19q codeletion, which is beneficial, and TERT wildtype, which is not, raises the question of which markers or combinations thereof most significantly affect survival [12, 28]. The gene discussed is TERT; the disease is central nervous system cancer.